Document is current
Any future updates will be listed below
-
Authors
Ngan, Esther
Bhandari, Prajwal
Parekh, Parag A.
Badachhape, Andrew A.
Annapragada, Ananth V.
Ghaghada, Ketan B.
Starosolski, Zbigniew A.
- License Information
-
More Information
Article History
Received: 2 February 2025
Accepted: 1 April 2026
First Online: 10 April 2026
Declarations
:
: All animal procedures were conducted in accordance with the guidelines set forth by the Institutional Animal Care and Use Committee (IACUC) at Baylor College of Medicine/Texas Children’s Hospital, and the study was approved under protocol number AN-5977.
: Not applicable.
: ZAS reports a relationship with Alzeca Biosciences, Inc. that includes: equity or stocks. AVA reports a relationship with Alzeca Biosciences Inc., Sensulin LLC that includes: board membership and equity or stocks, has patent Patent No. 11116854 issued to Texas Children’s Hospital. KBG reports a relationship with Alzeca Biosciences, Inc. that includes: consulting or advisory, has patent Patent No. 11116854 issued to Texas Children’s Hospital.
